Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic.
Akerman A, Fichter C, Milogiannakis V, Esneau C, Silva MR, Ison T, Lopez JA, Naing Z, Caguicla J, Amatayakul-Chantler S, Roth N, Manni S, Hauser T, Barnes T, Boss T, Condylios A, Yeang M, Sato K, Bartlett NN, Darley D, Matthews G, Stark DJ, Promsri S, Rawlinson WD, Murrell B, Kelleher AD, Dwyer D, Sintchenko V, Kok J, Ellis S, Marris K, Knight E, Hoad VC, Irving DO, Gosbell I, Brilot F, Wood J, Aggarwal A, Turville SG. Akerman A, et al. Among authors: milogiannakis v. EBioMedicine. 2024 Dec;110:105415. doi: 10.1016/j.ebiom.2024.105415. Epub 2024 Nov 15. EBioMedicine. 2024. PMID: 39549677 Free PMC article.
Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial.
Singer J, Tunbridge MJ, Shi B, Perkins GB, Chai CS, Salehi T, Sim BZ, Kireta S, Johnston JK, Akerman A, Milogiannakis V, Aggarwal A, Turville S, Hissaria P, Ying T, Wu H, Grubor-Bauk B, Coates PT, Chadban SJ. Singer J, et al. Among authors: milogiannakis v. Vaccines (Basel). 2024 Jun 3;12(6):608. doi: 10.3390/vaccines12060608. Vaccines (Basel). 2024. PMID: 38932337 Free PMC article.
Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection.
Phetsouphanh C, Jacka B, Ballouz S, Jackson KJL, Wilson DB, Manandhar B, Klemm V, Tan HX, Wheatley A, Aggarwal A, Akerman A, Milogiannakis V, Starr M, Cunningham P, Turville SG, Kent SJ, Byrne A, Brew BJ, Darley DR, Dore GJ, Kelleher AD, Matthews GV. Phetsouphanh C, et al. Among authors: milogiannakis v. Nat Commun. 2024 Apr 17;15(1):3315. doi: 10.1038/s41467-024-47720-8. Nat Commun. 2024. PMID: 38632311 Free PMC article.
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
Bowden-Reid E, Ledger S, Zhang Y, Di Giallonardo F, Aggarwal A, Stella AO, Akerman A, Milogiannakis V, Walker G, Rawlinson W, Turville S, Kelleher AD, Ahlenstiel C. Bowden-Reid E, et al. Among authors: milogiannakis v. Antiviral Res. 2023 Sep;217:105677. doi: 10.1016/j.antiviral.2023.105677. Epub 2023 Jul 20. Antiviral Res. 2023. PMID: 37478918 Free article.
Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core.
Poumbourios P, Langer C, Boo I, Zakir T, Center RJ, Akerman A, Milogiannakis V, Aggarwal A, Johnstone BA, Ha J, Coulibaly F, Turville SG, Drummer HE. Poumbourios P, et al. Among authors: milogiannakis v. PLoS Pathog. 2023 May 18;19(5):e1010981. doi: 10.1371/journal.ppat.1010981. eCollection 2023 May. PLoS Pathog. 2023. PMID: 37200378 Free PMC article.
Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients.
Alcheikh A, Perkins GB, Pucar PA, Cecchin A, Chai CS, Tunbridge M, Akerman A, Aggarwal A, Milogiannakis V, Turville S, Allen S, Hissaria P, Banovic T, Coates PT, Ross DM. Alcheikh A, et al. Among authors: milogiannakis v. Blood Cancer J. 2023 Apr 10;13(1):50. doi: 10.1038/s41408-023-00824-8. Blood Cancer J. 2023. PMID: 37032391 Free PMC article. No abstract available.
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level.
Akerman A, Milogiannakis V, Jean T, Esneau C, Silva MR, Ison T, Fichter C, Lopez JA, Chandra D, Naing Z, Caguicla J, Li D, Walker G, Amatayakul-Chantler S, Roth N, Manni S, Hauser T, Barnes T, Condylios A, Yeang M, Wong M, Foster CSP, Sato K, Lee S, Song Y, Mao L, Sigmund A, Phu A, Vande More AM, Hunt S, Douglas M, Caterson I, Britton W, Sandgren K, Bull R, Lloyd A, Triccas J, Tangye S, Bartlett NW, Darley D, Matthews G, Stark DJ, Petoumenos K, Rawlinson WD, Murrell B, Brilot F, Cunningham AL, Kelleher AD, Aggarwal A, Turville SG. Akerman A, et al. Among authors: milogiannakis v. EBioMedicine. 2023 Apr;90:104545. doi: 10.1016/j.ebiom.2023.104545. Epub 2023 Mar 30. EBioMedicine. 2023. PMID: 37002990 Free PMC article.
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells.
Phetsouphanh C, Khoo WH, Jackson K, Klemm V, Howe A, Aggarwal A, Akerman A, Milogiannakis V, Stella AO, Rouet R, Schofield P, Faulks ML, Law H, Danwilai T, Starr M, Munier CML, Christ D, Singh M, Croucher PI, Brilot-Turville F, Turville S, Phan TG, Dore GJ, Darley D, Cunningham P, Matthews GV, Kelleher AD, Zaunders JJ. Phetsouphanh C, et al. Among authors: milogiannakis v. Front Immunol. 2022 Dec 5;13:1032911. doi: 10.3389/fimmu.2022.1032911. eCollection 2022. Front Immunol. 2022. PMID: 36544780 Free PMC article.
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion.
Shen Y, Freeman JA, Holland J, Naidu K, Solterbeck A, Van Bilsen N, Downe P, Kerridge I, Wallman L, Akerman A, Aggarwal A, Milogiannakis V, Martins Costa Gomes G, Doyle CM, Sandgren KJ, Turville S, Cunningham AL, Mulligan SP. Shen Y, et al. Among authors: milogiannakis v. Blood. 2022 Dec 22;140(25):2709-2721. doi: 10.1182/blood.2022017814. Blood. 2022. PMID: 36206503 Free PMC article.
13 results